vs

Side-by-side financial comparison of Accelerant Holdings (ARX) and Cellebrite DI Ltd. (CLBT). Click either name above to swap in a different company.

Cellebrite DI Ltd. is the larger business by last-quarter revenue ($292.2M vs $267.4M, roughly 1.1× Accelerant Holdings). Cellebrite DI Ltd. runs the higher net margin — -103.5% vs -511.9%, a 408.4% gap on every dollar of revenue.

Accelerant Holdings is a global specialty insurance and reinsurance technology platform that leverages advanced data analytics and risk assessment tools to support insurance carriers, managing general agents, and underwriting partners. It delivers tailored risk solutions, streamlines underwriting workflows, and serves commercial and specialty insurance segments across North America and European markets.

Cellebrite DI Ltd. is a digital forensics company headquartered in Petah Tikva, Israel that provides tools for law enforcement agencies as well as enterprise companies and service providers to collect, review, analyze and manage digital data. Their flagship product series is the Cellebrite UFED.

ARX vs CLBT — Head-to-Head

Bigger by revenue
CLBT
CLBT
1.1× larger
CLBT
$292.2M
$267.4M
ARX
Higher net margin
CLBT
CLBT
408.4% more per $
CLBT
-103.5%
-511.9%
ARX

Income Statement — Q3 FY2025 vs Q3 FY2025

Metric
ARX
ARX
CLBT
CLBT
Revenue
$267.4M
$292.2M
Net Profit
$-1.4B
$-302.3M
Gross Margin
84.6%
Operating Margin
-507.7%
14.1%
Net Margin
-511.9%
-103.5%
Revenue YoY
Net Profit YoY
EPS (diluted)
$-6.99
$-1.50

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARX
ARX
CLBT
CLBT
Q3 25
$267.4M
$292.2M
Q2 25
$219.1M
$220.8M
Q1 25
$89.6M
Q3 24
$232.1M
Q2 24
$185.3M
Q1 24
$71.2M
Q3 23
$196.6M
Q2 23
$97.9M
Net Profit
ARX
ARX
CLBT
CLBT
Q3 25
$-1.4B
$-302.3M
Q2 25
$8.8M
$36.9M
Q1 25
$-71.4M
Q3 24
Q2 24
$-95.2M
Q1 24
$-40.6M
Q3 23
$113.7M
Q2 23
$-73.0M
Gross Margin
ARX
ARX
CLBT
CLBT
Q3 25
84.6%
Q2 25
84.1%
Q1 25
85.2%
Q3 24
83.5%
Q2 24
84.1%
Q1 24
82.6%
Q3 23
80.4%
Q2 23
Operating Margin
ARX
ARX
CLBT
CLBT
Q3 25
-507.7%
14.1%
Q2 25
10.2%
12.1%
Q1 25
10.3%
Q3 24
7.9%
Q2 24
11.7%
Q1 24
0.2%
Q3 23
-4.4%
Q2 23
4.9%
Net Margin
ARX
ARX
CLBT
CLBT
Q3 25
-511.9%
-103.5%
Q2 25
4.0%
16.7%
Q1 25
-79.7%
Q3 24
Q2 24
-51.4%
Q1 24
-57.0%
Q3 23
57.8%
Q2 23
-74.5%
EPS (diluted)
ARX
ARX
CLBT
CLBT
Q3 25
$-6.99
$-1.50
Q2 25
$0.04
$0.15
Q1 25
$-0.36
Q3 24
$-0.35
Q2 24
$-0.48
Q1 24
$-0.21
Q3 23
$0.56
Q2 23
$-0.37

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARX
ARX
CLBT
CLBT
Cash + ST InvestmentsLiquidity on hand
$1.6B
$191.7M
Total DebtLower is stronger
$121.9M
Stockholders' EquityBook value
$676.1M
$336.0M
Total Assets
$7.9B
$690.6M
Debt / EquityLower = less leverage
0.18×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARX
ARX
CLBT
CLBT
Q3 25
$1.6B
$191.7M
Q2 25
$1.4B
$326.1M
Q1 25
$191.7M
Q3 24
$189.5M
Q2 24
$178.6M
Q1 24
$189.5M
Q3 23
$87.6M
Q2 23
$168.1M
Total Debt
ARX
ARX
CLBT
CLBT
Q3 25
$121.9M
Q2 25
$126.7M
Q1 25
Q3 24
Q2 24
Q1 24
Q3 23
Q2 23
Stockholders' Equity
ARX
ARX
CLBT
CLBT
Q3 25
$676.1M
$336.0M
Q2 25
$346.2M
$408.4M
Q1 25
$336.0M
Q3 24
$34.2M
Q2 24
$-40.2M
Q1 24
$34.2M
Q3 23
$73.9M
Q2 23
$17.6M
Total Assets
ARX
ARX
CLBT
CLBT
Q3 25
$7.9B
$690.6M
Q2 25
$7.5B
$787.4M
Q1 25
$690.6M
Q3 24
$532.9M
Q2 24
$556.6M
Q1 24
$532.9M
Q3 23
$403.3M
Q2 23
$425.9M
Debt / Equity
ARX
ARX
CLBT
CLBT
Q3 25
0.18×
Q2 25
0.37×
Q1 25
Q3 24
Q2 24
Q1 24
Q3 23
Q2 23

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARX
ARX
CLBT
CLBT
Operating Cash FlowLast quarter
$73.9M
$66.2M
Free Cash FlowOCF − Capex
$60.8M
FCF MarginFCF / Revenue
20.8%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$172.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARX
ARX
CLBT
CLBT
Q3 25
$73.9M
$66.2M
Q2 25
$309.3M
$53.5M
Q1 25
$10.0M
Q3 24
$58.2M
Q2 24
$24.6M
Q1 24
$12.5M
Q3 23
$-15.2M
Q2 23
$29.1M
Free Cash Flow
ARX
ARX
CLBT
CLBT
Q3 25
$60.8M
Q2 25
$47.5M
Q1 25
$8.5M
Q3 24
$55.3M
Q2 24
$21.0M
Q1 24
$11.4M
Q3 23
$-20.7M
Q2 23
$27.2M
FCF Margin
ARX
ARX
CLBT
CLBT
Q3 25
20.8%
Q2 25
21.5%
Q1 25
9.5%
Q3 24
23.8%
Q2 24
11.3%
Q1 24
16.0%
Q3 23
-10.5%
Q2 23
27.8%
Capex Intensity
ARX
ARX
CLBT
CLBT
Q3 25
1.8%
Q2 25
2.7%
Q1 25
1.7%
Q3 24
1.3%
Q2 24
1.9%
Q1 24
1.5%
Q3 23
2.8%
Q2 23
1.9%
Cash Conversion
ARX
ARX
CLBT
CLBT
Q3 25
Q2 25
35.15×
1.45×
Q1 25
Q3 24
Q2 24
Q1 24
Q3 23
-0.13×
Q2 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ARX
ARX

Underwriting Segment$117.6M44%
Exchange Services Segment$85.0M32%
Other$64.8M24%

CLBT
CLBT

Subscription services$197.2M67%
Term-license$60.8M21%
Professional services$23.2M8%
Other non-recurring$11.0M4%

Related Comparisons